El sitio web cubano de InmunologÃa propone a nuestros usuarios la lectura de un grupo de artÃculos cientÃficos sobre el auge de los anticuerpos monoclonales para el tratamiento de diferentes enfermedades, tales como lupus, malaria, párkinson, hemofilia A, cáncer y enfermedad de Huntington.
– Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
– Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria.
– Monoclonal Antibodies — A Different Approach to Combat Malaria.
– Monoclonal Antibodies for Malaria.
– Monoclonal Antibody Therapy in Parkinson’s Disease — The End?
– An anti-CTLA-4 heavy chain–only antibody with enhanced Treg depletion shows excellent preclinical efficacy and safety profile.
– Pepinemab antibody blockade of SEMA4D in early Huntington’s disease: a randomized, placebo-controlled, phase 2 trial.
– Emicizumab in children: bleeding episodes and outcome before and after transition to Emicizumab.
